Current Cardiology Reports
-
Publication Venue For
- Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs.. 24:1397-1406. 2022
- Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach.. 24:1373-1385. 2022
- Subcutaneous and Transvenous ICDs: an Update on Contemporary Questions and Controversies.. 24:947-958. 2022
- Invasive Hemodynamic Evaluation of the Fontan Circulation: Current Day Practice and Limitations.. 24:587-596. 2022
- Contemporary Management of Abdominal Aortic Aneurysms.. 24:431-438. 2022
- Anesthetic Management in Adults with Congenital Heart Disease.. 24:235-246. 2022
- Burden and Impact of Arrhythmias in Repaired Tetralogy of Fallot.. 24:225-234. 2022
- Stroke Prevention in Patients with Patent Foramen Ovale.. 23:183. 2021
- Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians?. 23:181. 2021
- Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19.. 23:168. 2021
- Chronic Thromboembolic Pulmonary Hypertension: the Bedside.. 23:147. 2021
- Chronic Thromboembolic Pulmonary Hypertension: the Bench.. 23:141. 2021
- Successful Peripheral Vascular Intervention in Patients with High-risk Comorbidities or Lesion Characteristics.. 23:32. 2021
- A Roadmap to Heart Regeneration Through Conserved Mechanisms in Zebrafish and Mammals.. 23:29. 2021
- The Current Evidence for Lipid Management in Patients with Lower Extremity Peripheral Artery Disease: What Is the Therapeutic Target?. 23:13. 2021
- Intensive Care Unit Management of the Adult with Congenital Heart Disease.. 22:136. 2020
- Biventricular Conversion in the Borderline Hypoplastic Heart.. 22:115. 2020
- Pacing in Patients with Congenital Heart Disease: When Is It Helpful and When Is It Harmful?. 22:5. 2020
- Management of Pulmonary Arterial Hypertension in the Pediatric Patient.. 21:162. 2019
- Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations.. 21:161. 2019
- Valvular Disease in Marfan Syndrome: Surgical Considerations and Management.. 21:23. 2019
- Recent Advances in Congenital Heart Surgery: Alternative Perfusion Strategies for Infant Aortic Arch Repair.. 21:13. 2019
- Asymptomatic Severe Aortic Valve Stenosis-When to Intervene: a Review of the Literature, Current Trials, and Guidelines.. 20:129. 2018
- Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.. 20:130. 2018
- Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?. 20:105. 2018
- Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease.. 20:81. 2018
- Challenges in Aortic Valve Stenosis: Low-Flow States Diagnosis, Management, and a Review of the Current Literature.. 19:130. 2017
- Improving Medication Adherence in Coronary Heart Disease.. 19:113. 2017
- Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.. 19:108. 2017
- Congenital and Acquired Valvular Heart Disease in Pregnancy.. 19:96. 2017
- Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease.. 19:72. 2017
- Coronary Artery Anomalies: When You Need to Worry.. 19:39. 2017
- Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies.. 18:128. 2016
- The Effect of Vigorous- Versus Moderate-Intensity Aerobic Exercise on Insulin Action.. 18:117. 2016
- Cardiovascular Complications of HIV in Endemic Countries.. 18:113. 2016
- A Bridge to Nowhere? Benefits and Risks for Periprocedural Anticoagulation in Atrial Fibrillation.. 18:101. 2016
- Rheumatic Heart Disease in the Twenty-First Century.. 18:96. 2016
- The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease.. 18:81. 2016
- Hypertrophic Cardiomyopathy: New Evidence Since the 2011 American Cardiology of Cardiology Foundation and American Heart Association Guideline.. 18:70. 2016
- Coronary CT Angiography as a Diagnostic and Prognostic Tool: Perspective from a Multicenter Randomized Controlled Trial: PROMISE.. 18:40. 2016
- Antithrombotic Therapy After Peripheral Vascular Intervention.. 18:26. 2016
- Current State of Stem Cell Therapy for Ischemic Heart Disease.. 18:17. 2016
- Emotional triggering of cardiac dysfunction: the present and future.. 17:91. 2015
- Limb ischemia: cardiovascular diagnosis and management from head to toe.. 17:611. 2015
- Current status of percutaneous PFO closure.. 16:477. 2014
- Appropriateness of percutaneous coronary intervention: a review.. 15:379. 2013
- Transcatheter aortic valve replacement: an update.. 15:367. 2013
- Cigarette smoking and clopidogrel interaction.. 15:361. 2013
- Interventional treatment of hypertension: a new paradigm.. 15:356. 2013
- Approaches to decongestion in patients with acute decompensated heart failure.. 15:335. 2013
- Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.. 15:330. 2013
- Clopidogrel and PPI interaction: clinically relevant or not?. 14:49-58. 2012
- Promise of factor Xa inhibition in atrial fibrillation.. 14:70-78. 2012
- The role of cardiac MR in new-onset heart failure.. 13:185-193. 2011
- Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?. 12:315-320. 2010
- Echocardiographic quantification of left ventricular mass: prognostic implications.. 12:277-282. 2010
- Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction?. 12:155-161. 2010
- In hypertension, the kidney breaks your heart.. 10:470-476. 2008
- Early intervention: which patients and how early?. 10:303-311. 2008
- Late adverse events after drug-eluting stent implantation.. 10:253-262. 2008
- Lessons learned from the CRUSADE National Quality Improvement Initiative.. 10:285-290. 2008